banner add

F.D.A. Panel’s Vote on Peptides Raises Concerns About a Prescribing Boom

The committee endorsed broader use of the peptides in lightly regulated compounding pharmacies that have grown into a multibillion-dollar business.

from NYT > Health https://ift.tt/eyOwdbT
via IFTTT

No comments

C.D.C. Director Challenges Pennsylvania’s Report of Two Measles Deaths

Questioning a state’s investigation is highly unusual for the public health agency, but reflects tensions between the Trump administration a...

Theme images by PLAINVIEW. Powered by Blogger.